Pau Montesinos

Trials

Studies that name Pau Montesinos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:01 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07507760 · Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

  PETHEMA Foundation · recruiting · Acute Myeloid Leukemia With Gene Mutations · study chair
• N/A
  NCT05541224 · A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers

  PETHEMA Foundation · completed · Acute Myeloid Leukemia · study chair
• Ph1/Ph2
  NCT04687761 · Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

  PETHEMA Foundation · completed · Leukemia, Myeloid, Acute, De Novo, Age More 60yr · principal investigator
• N/A
  NCT04446741 · Molecular Diagnostic Platform for AML

  PETHEMA Foundation · unknown · Acute Myeloid Leukemia (AML) · principal investigator
• N/A
  NCT04369287 · Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia

  Istituto Clinico Humanitas · unknown · Acute Myeloid Leukemia, IDH1 Gene Mutation, IDH2 Gene Mutation · principal investigator
• Ph2
  NCT04230239 · Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

  PETHEMA Foundation · completed · Newly Diagnosed Secondary or High Risk AML · principal investigator
• Ph1/Ph2
  NCT04112589 · A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment

  PETHEMA Foundation · unknown · Acute Myeloid Leukemia · study director
• Ph2
  NCT04107727 · Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)

  PETHEMA Foundation · completed · Acute Myeloid Leukemia · principal investigator
• N/A
  NCT03311815 · Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.

  PETHEMA Foundation · completed · Acute Myeloid Leukemia · principal investigator
• Ph3
  NCT02319135 · Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

  PETHEMA Foundation · completed · Acute Myeloid Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.